Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Relating radiation-induced regional lung injury to changes in pulmonary function testsM Fan, L B Marks, P Lind, et al.Journal of Medicinal Chemistry|March 29, 2012
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerasesSumandeep K Gill, Hao Xu, Paul D Kirchhoff, et al.International Journal of Radiation Oncology, Biology, Physics|October 13, 2001
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancerM L Hernando, L B Marks, G C Bentel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.International Journal of Radiation Oncology, Biology, Physics|October 23, 1997
Physical and biological predictors of changes in whole-lung function following thoracic irradiationL B Marks, M T Munley, G C Bentel, et al.American Journal of Medical Genetics. Part A|February 13, 2013
Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome ProjectNaTasha D Hollis, Emily G Allen, Tiffany Renee Oliver, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|October 12, 2011
Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome ProjectLora J H Bean, Emily G Allen, Stuart W Tinker, et al.Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitorsTuan P Tran, Edmund L Ellsworth, Joseph P Sanchez, et al.Journal of Medicinal Chemistry|October 27, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organismsEdmund L Ellsworth, Tuan P Tran, H D Hollis Showalter, et al.Journal of Medicinal Chemistry|February 17, 2006
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptorsSylvester R Klutchko, Hairong Zhou, R Thomas Winters, et al.Pageof 8